Should postprandial glucose be measured and treated to a particular target? Yes

被引:29
作者
Davidson, J [1 ]
机构
[1] Endocrine & Diabet Assoc Texas, UTSWMS, Dallas, TX 75230 USA
关键词
D O I
10.2337/diacare.26.6.1919
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
引用
收藏
页码:1919 / 1921
页数:3
相关论文
共 33 条
[1]
Response to intensive therapy steps and to glipizide dose in combination with insulin in type 2 diabetes: VA feasibility study on glycemic control and complications (VA CSDM) [J].
Abraira, C ;
Henderson, WG ;
Colwell, JA ;
Nuttall, FQ ;
Comstock, JP ;
Emanuele, NV ;
Levin, SR ;
Sawin, CT ;
Silbert, CK .
DIABETES CARE, 1998, 21 (04) :574-579
[2]
American Diabetes Association, 2001, Diabetes Care, V24, P775
[3]
Nonfasting plasma glucose is a better marker of diabetic control than fasting plasma glucose in type 2 diabetes [J].
Avignon, A ;
Radauceanu, A ;
Monnier, L .
DIABETES CARE, 1997, 20 (12) :1822-1826
[4]
Therapy focused on lowering postprandial glucose, not fasting glucose, may be superior for lowering HbA1c [J].
Bastyr, EJ ;
Stuart, CA ;
Brodows, RG ;
Schwartz, S ;
Graf, CJ ;
Zagar, A ;
Robertson, KE .
DIABETES CARE, 2000, 23 (09) :1236-1241
[5]
Plasma glucose levels throughout the day and HbA1c interrelationships in type 2 diabetes -: Implications for treatment and monitoring of metabolic control [J].
Bonora, E ;
Calcaterra, F ;
Lombardi, S ;
Bonfante, N ;
Formentini, G ;
Bonadonna, RC ;
Muggeo, M .
DIABETES CARE, 2001, 24 (12) :2023-2029
[6]
Borch-Johnsen K, 1999, LANCET, V354, P617
[7]
Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population:: the Hoorn Study [J].
de Vegt, F ;
Dekker, JM ;
Ruhé, HG ;
Stehouwer, CDA ;
Nijpels, G ;
Bouter, LM ;
Heine, RJ .
DIABETOLOGIA, 1999, 42 (08) :926-931
[8]
DEVECIANA M, 1995, NEW ENGL J MED, V333, P1239
[9]
POSTCHALLENGE GLUCOSE-CONCENTRATION AND CORONARY HEART-DISEASE IN MEN OF JAPANESE ANCESTRY - HONOLULU HEART PROGRAM [J].
DONAHUE, RP ;
ABBOTT, RD ;
REED, DM ;
YANO, K .
DIABETES, 1987, 36 (06) :689-692
[10]
Edelman SV, 2002, DIAGNOSIS MANAGEMENT